semaglutide and thyroid cancer GLP-1 Weight Loss Medication Risks Explained Thyroid Cancer and GLP-1 Medications:

Unlike stimulant-based weight loss products, ReadyRx - GLP-1 works with the body's regulatory systems instead of overriding them

PalaRBeyazFTuzcuMErBSahinNCinarVet al

Free radicals can damage cells and cause chronic diseases like cancer, heart disease, and neurological disorders (131)

These include: Nausea (reported in 11.9-24.0% of patients, depending on dose) Diarrhoea (13.3-22.1%) Vomiting (4.9-10.5%) Constipation (5.3-9.1%) These symptoms, which can indirectly contribute to taste changes, were generally mild to moderate in severity and tended to decrease over time as patients became accustomed to the medication